Long‐Term Survival for Hemodialysis Patients Differ in Japan Versus Europe and the USA. What Might the Reasons Be?

Matsuda, Kazuo; Fissell, Rachel B.; Ash, Stephen R.; Stegmayr, Bernd

doi:10.1111/aor.13363

Cited by 14 publications

(21 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another common reason for congestive heart failure is the retention of fluid between the dialyses. This volume overload, the interdialytic weight gain (IDWG) [11,12], may even be hidden if the dry weight is lowered due to catabolism [12].…”

Section: Introductionmentioning

confidence: 99%

NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report

et al. 2020

Self Cite

View full text Add to dashboard Cite

Background An arteriovenous fistula (AVF) is the first choice when considering access for haemodialysis (HD). When a forearm AVF fails an upper arm AVF is a frequent subsequent dialysis access option. The latter may cause cardiac strain. NT-pro-B-type natriuretic peptide (NT-NT-proBNP) is a marker used to estimate volume overload and cardiac strain. This case report shows the benefit of using longitudinal individual follow-up of pre-dialysis NT-proBNP in clinical practice to detect changes in cardiac condition that may be due to high-output AVF. Case presentation An 18 years old patient performed HD via an upper arm AVF before he was admitted to our unit. NT-proBNP was above the upper detection level of 70,000 ng/L. Echocardiography revealed a left-ventricular cardiac insufficiency. Interdialytic weight gain (IDWG) was above 5%. He was instructed to lower fluid intake and IDWG towards 2%. Four months later NT-proBNP surpassed 70,000 ng/L again. Flow in the brachial artery was at 3034 ml/min. Reconstructive surgery of the AVF did not reduce flow and NT-proBNP in the long run. Clinically, he worsened to NYHA class III-IV. It was decided to close the upper arm AVF and to replace it with a lower arm AVF leading to a reduced artery flow of 1344 mL/min. The clinical condition successively recovered and NT-proBNP decreased to 7000 ng/L. Conclusions Pre-dialysis NT-proBNP should be considered as a suitable routine marker for cardiac strain such as caused by high-output AVF besides variables such as IDWG. Brachial artery flow besides AVF flow measurement is helpful.

show abstract

Section: Introductionmentioning

confidence: 99%

NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

“…In multiple analyses adjusted for such variables, superior survival was seen in Japan versus other countries . As Matsuda et al point out, differences in comorbid characteristics between Japanese hemodialysis patients and those from other countries do not fully explain the superior survival seen in Japanese patients on hemodialysis and that differences in practice patterns likely contribute and there are cultural differences that may favor survival as well such as the Japanese patients are more likely to stay for the full treatment times of their dialysis prescription and adhere to dietary recommendations.…”

mentioning

confidence: 99%

“…While data worldwide on mortality rates is limited, a 2007 report noted that US mortality risk as 15% higher than in Europe and 33% higher than in Japan. In a recent publication, Matsuda et al addressed the issue of long‐term survival in hemodialysis patients from Japan, Europe, and the United States. As they point out, Japanese patients live longer on hemodialysis and despite those patients in the United States being older and having a higher prevalence of comorbid conditions.…”

mentioning

confidence: 99%

Renal support: A time to reassess the direction!

Malchesky¹

2019

Artificial Organs

View full text Add to dashboard Cite

“…The relationship between kidney disease mortality and morbidity is complex. Where renal replacement therapy is available a loss of over 90% of kidney function is compatible with decades of survival on this therapy [9]. On the other hand, the presence of any degree of reduction in kidney function is associated with an increased risk of death, directly proportional to reduction in kidney function [10].…”

mentioning

confidence: 99%

Chronic Kidney Disease: The Complex History of the Organization of Long-Term Care and Bioethics. Why Now, More Than Ever, Action is Needed

Versino

Piccoli

2019

IJERPH

View full text Add to dashboard Cite

Chronic kidney disease (CKD) has been redefined in the new millennium as any alteration of kidney morphology, function, blood, or urine composition lasting for at least 3 months. This broad definition also encompasses diseases or conditions that are associated with normal kidney function, such as a kidney scarring from an acute pyelonephritis episode or a single kidney, as a result of kidney donation. CKD is a relevant public health problem. According to the 2015 Global Burden of Disease Study, it was the 12th leading cause of death, leading to 1.1 million deaths, worldwide, each year. The role of CKD as a cause of death is evident where renal replacement therapy (RRT) is not available, however, its role in increasing death risk is not easily calculated. RRT consumes about 3–5% of the global healthcare budget where dialysis is available without restrictions. While the prevalence of CKD is increasing overall as lifespans extend, being linked to diabetes, hypertension, obesity, and atherosclerosis, CKD is at least partly preventable and its effects may be at least partly counterbalanced by early and appropriate care. We will welcome papers on all aspects of CKD, including organization, cost, and models of care. Papers from developing countries will be particularly welcomed.

show abstract

Long‐Term Survival for Hemodialysis Patients Differ in Japan Versus Europe and the USA. What Might the Reasons Be?

Cited by 14 publications

References 43 publications

NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report

NT-pro-BNP as marker for cardiac strain that may be caused by high-output arteriovenous shunting in a haemodialysis patient. A case report

Renal support: A time to reassess the direction!

Chronic Kidney Disease: The Complex History of the Organization of Long-Term Care and Bioethics. Why Now, More Than Ever, Action is Needed

Contact Info

Product

Resources

About